Enzo Biochem Debt to Equity Ratio 2006-2019 | ENZ

Current and historical debt to equity ratio values for Enzo Biochem (ENZ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Enzo Biochem debt/equity for the three months ending January 31, 2019 was 0.05.
Enzo Biochem Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-01-31 $0.00B $0.07B 0.07
2018-10-31 $0.00B $0.08B 0.00
2018-07-31 $0.00B $0.08B 0.00
2018-04-30 $0.00B $0.09B 0.00
2018-01-31 $0.00B $0.09B 0.00
2017-10-31 $0.00B $0.09B 0.00
2017-07-31 $0.00B $0.09B 0.00
2017-04-30 $0.00B $0.09B 0.00
2017-01-31 $0.00B $0.09B 0.00
2016-10-31 $0.00B $0.09B 0.00
2016-07-31 $0.00B $0.09B 0.00
2016-04-30 $0.00B $0.05B 0.00
2016-01-31 $0.00B $0.05B 0.00
2015-10-31 $0.00B $0.05B 0.00
2015-07-31 $0.00B $0.04B 0.00
2015-04-30 $0.00B $0.03B 0.00
2015-01-31 $0.00B $0.04B 0.00
2014-10-31 $0.00B $0.04B 0.00
2014-07-31 $0.00B $0.04B 0.00
2014-04-30 $0.00B $0.04B 0.00
2014-01-31 $0.00B $0.03B 0.00
2013-10-31 $0.00B $0.03B 0.00
2013-07-31 $0.00B $0.03B 0.00
2013-04-30 $0.00B $0.04B 0.00
2013-01-31 $0.00B $0.04B 0.00
2012-10-31 $0.00B $0.05B 0.00
2012-07-31 $0.00B $0.05B 0.00
2012-04-30 $0.00B $0.08B 0.00
2012-01-31 $0.00B $0.08B 0.00
2011-10-31 $0.00B $0.08B 0.00
2011-07-31 $0.00B $0.09B 0.00
2011-04-30 $0.00B $0.09B 0.00
2011-01-31 $0.00B $0.09B 0.00
2010-10-31 $0.00B $0.10B 0.00
2010-07-31 $0.00B $0.10B 0.00
2010-04-30 $0.00B $0.10B 0.00
2010-01-31 $0.00B $0.11B 0.00
2009-10-31 $0.00B $0.12B 0.00
2009-07-31 $0.00B $0.12B 0.00
2009-04-30 $0.00B $0.12B 0.00
2009-01-31 $0.00B $0.12B 0.00
2008-10-31 $0.00B $0.13B 0.00
2008-07-31 $0.00B $0.14B 0.00
2008-04-30 $0.00B $0.14B 0.00
2008-01-31 $0.00B $0.14B 0.00
2007-10-31 $0.00B $0.14B 0.00
2007-07-31 $0.00B $0.14B 0.00
2007-04-30 $0.00B $0.15B 0.00
2007-01-31 $0.00B $0.13B 0.00
2006-10-31 $0.00B $0.10B 0.00
2006-07-31 $0.00B $0.10B 0.00
2006-04-30 $0.00B $0.10B 0.00
2006-01-31 $0.00B $0.10B 0.00
2005-10-31 $0.00B $0.11B 0.00
2005-07-31 $0.00B $0.11B 0.00
2005-04-30 $0.00B $0.11B 0.00
2005-01-31 $0.00B $0.11B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.177B $0.105B
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $112.497B 12.72
Gilead Sciences (GILD) United States $87.305B 10.60
Celgene (CELG) United States $65.723B 11.13
Illumina (ILMN) United States $52.638B 61.00
Biogen (BIIB) United States $46.591B 8.84
Vertex Pharmaceuticals (VRTX) United States $46.140B 55.77
Regeneron Pharmaceuticals (REGN) United States $34.192B 16.07
Alexion Pharmaceuticals (ALXN) United States $28.063B 15.88
Incyte (INCY) United States $18.787B 76.18
BioMarin Pharmaceutical (BMRN) United States $15.010B 0.00
Exact Sciences (EXAS) United States $14.393B 0.00
Seattle Genetics (SGEN) United States $11.136B 0.00
Array BioPharma (ARRY) United States $10.247B 0.00
Sarepta Therapeutics (SRPT) United States $9.207B 0.00
QIAGEN (QGEN) Netherlands $9.104B 29.90
Bio-Techne Corp (TECH) United States $7.705B 52.57
Alnylam Pharmaceuticals (ALNY) United States $7.579B 0.00
Guardant Health (GH) United States $7.547B 0.00
Bluebird Bio (BLUE) United States $6.610B 0.00
Galapagos (GLPG) Belgium $6.470B 0.00
Exelixis (EXEL) United States $6.379B 16.26
Amarin (AMRN) Ireland $6.009B 0.00
BeiGene (BGNE) Cayman Islands $5.645B 0.00
Ascendis Pharma (ASND) Denmark $5.084B 0.00
Moderna (MRNA) United States $4.530B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.480B 0.00
Blueprint Medicines (BPMC) United States $4.479B 0.00
Spark Therapeutics (ONCE) United States $3.872B 0.00
Repligen (RGEN) United States $3.800B 94.67
ACADIA Pharmaceuticals (ACAD) United States $3.717B 0.00
China Biologic Products (CBPO) China $3.705B 23.53
Mirati Therapeutics (MRTX) United States $3.682B 0.00
Global Blood Therapeutics (GBT) United States $3.521B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.421B 0.00
Alkermes (ALKS) Ireland $3.417B 0.00
Allogene Therapeutics (ALLO) United States $3.181B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.129B 0.00
UniQure (QURE) Netherlands $2.835B 0.00
Amicus Therapeutics (FOLD) United States $2.779B 0.00
Arena Pharmaceuticals (ARNA) United States $2.776B 5.64
Lion Biotechnologies (IOVA) United States $2.686B 0.00
Reata Pharmaceuticals (RETA) United States $2.552B 0.00
Medicines (MDCO) United States $2.495B 0.00
Immunomedics (IMMU) United States $2.490B 0.00
Emergent Biosolutions (EBS) United States $2.421B 21.03
Halozyme Therapeutics (HALO) United States $2.369B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.334B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.327B 0.00
NeoGenomics (NEO) United States $2.156B 141.13
Ligand Pharmaceuticals (LGND) United States $2.154B 17.84
Akcea Therapeutics (AKCA) United States $2.152B 0.00
MyoKardia (MYOK) United States $2.110B 0.00
Acceleron Pharma (XLRN) United States $2.086B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $2.016B 0.00
Genomic Health (GHDX) United States $2.004B 42.57
Insmed (INSM) United States $1.987B 0.00
Denali Therapeutics (DNLI) United States $1.929B 0.00
REGENXBIO (RGNX) United States $1.842B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.772B 0.00
Allakos (ALLK) United States $1.743B 0.00
Myriad Genetics (MYGN) United States $1.663B 16.55
Audentes Therapeutics (BOLD) United States $1.656B 0.00
Cambrex (CBM) United States $1.511B 19.11
Apellis Pharmaceuticals (APLS) United States $1.506B 0.00
AnaptysBio (ANAB) United States $1.484B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.471B 0.00
Coherus BioSciences (CHRS) United States $1.466B 0.00
Gossamer Bio (GOSS) United States $1.458B 0.00
Innoviva (INVA) United States $1.417B 3.92
Fate Therapeutics (FATE) United States $1.285B 0.00
Alector (ALEC) United States $1.227B 0.00
Aimmune Therapeutics (AIMT) United States $1.222B 0.00
Athenex (ATNX) United States $1.207B 0.00
Epizyme (EPZM) United States $1.207B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.192B 0.00
Rubius Therapeutics (RUBY) United States $1.167B 0.00
RA PHARMCTL INC (RARX) United States $1.153B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.147B 0.00
Editas Medicine (EDIT) United States $1.124B 0.00
Sangamo Therapeutics (SGMO) United States $1.122B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.080B 0.00
G1 THERAPEUTICS (GTHX) United States $1.034B 0.00
CORTEXYME INC (CRTX) United States $1.021B 0.00
Codexis (CDXS) United States $1.005B 0.00
Twist Bioscience (TWST) United States $0.954B 0.00
NGM Biopharmaceuticals (NGM) United States $0.952B 0.00
ANI Pharmaceuticals (ANIP) United States $0.939B 16.65
Eidos Therapeutics (EIDX) United States $0.932B 0.00
Atara Biotherapeutics (ATRA) United States $0.926B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.922B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.908B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.905B 0.00
WAVE Life Sciences (WVE) Singapore $0.887B 0.00
Zymeworks (ZYME) Canada $0.875B 0.00
Retrophin (RTRX) United States $0.830B 0.00
Principia Biopharma (PRNB) United States $0.815B 0.00
Axsome Therapeutics (AXSM) United States $0.799B 0.00
Cara Therapeutics (CARA) United States $0.784B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.776B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.775B 0.00
Vericel (VCEL) United States $0.773B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.769B 0.00
MeiraGTx Holdings (MGTX) United States $0.766B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.755B 0.00
Kura Oncology (KURA) United States $0.747B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.741B 35.00
Rhythm Pharmaceuticals (RYTM) United States $0.737B 0.00
Arvinas (ARVN) United States $0.726B 0.00
Intra-Cellular Therapies (ITCI) United States $0.719B 0.00
Clovis Oncology (CLVS) United States $0.711B 0.00
Adverum Biotechnologies (ADVM) United States $0.702B 0.00
Intellia Therapeutics (NTLA) United States $0.681B 0.00
Precision BioSciences (DTIL) United States $0.665B 0.00
Myovant Sciences (MYOV) United Kingdom $0.658B 0.00
Zealand Pharma (ZEAL) Denmark $0.648B 7.57
Stemline Therapeutics (STML) United States $0.647B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.638B 0.00
Heska (HSKA) United States $0.636B 65.14
Cytokineticsorporated (CYTK) United States $0.626B 0.00
Cellectis (CLLS) France $0.618B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.611B 0.00
Krystal Biotech (KRYS) United States $0.582B 0.00
Viking Therapeutics (VKTX) United States $0.578B 0.00
Anika Therapeutics (ANIK) United States $0.549B 18.74
Milestone Pharmaceuticals (MIST) Canada $0.545B 0.00
Revance Therapeutics (RVNC) United States $0.535B 0.00
Mesoblast (MESO) Australia $0.527B 0.00
ObsEva SA (OBSV) Switzerland $0.525B 0.00
Magenta Therapeutics (MGTA) United States $0.498B 0.00
Puma Biotechnology (PBYI) United States $0.493B 0.00
DBV Technologies (DBVT) France $0.492B 0.00
CytomX Therapeutics (CTMX) United States $0.479B 0.00
BeyondSpring (BYSI) United States $0.466B 0.00
Provention Bio (PRVB) United States $0.454B 0.00
Replimune (REPL) United States $0.453B 0.00
UROGEN PHARMA (URGN) United States $0.452B 0.00
Sorrento Therapeutics (SRNE) United States $0.436B 0.00
Arcus Biosciences (RCUS) United States $0.422B 0.00
Kodiak Sciences (KOD) United States $0.421B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.417B 0.00
Agenus (AGEN) United States $0.408B 0.00
MediciNova (MNOV) United States $0.405B 0.00
Synthorx (THOR) United States $0.403B 0.00
Prothena (PRTA) Ireland $0.393B 0.00
Scholar Rock Holding (SRRK) United States $0.392B 0.00
BioDelivery Sciences (BDSI) United States $0.389B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.377B 0.00
Kaleido Biosciences (KLDO) $0.377B 0.00
AVROBIO (AVRO) United States $0.375B 0.00
Albireo Pharma (ALBO) United States $0.374B 0.00
UNITY Biotechnology (UBX) $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.369B 0.00
PDL BioPharma (PDLI) United States $0.369B 8.80
ProQR Therapeutics (PRQR) Netherlands $0.363B 0.00
ResTORbio (TORC) United States $0.357B 0.00
AC Immune SA (ACIU) Switzerland $0.355B 22.87
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.355B 0.00
Gritstone Oncology (GRTS) United States $0.351B 0.00
Senesco Technologies (ELOX) United States $0.345B 0.00
Acorda Therapeutics (ACOR) United States $0.340B 5.98
NuCana Sponsored ADR (NCNA) United Kingdom $0.339B 0.00
Kindred Biosciences (KIN) United States $0.333B 0.00
Syros Pharmaceuticals (SYRS) United States $0.319B 0.00
Merus (MRUS) Netherlands $0.316B 0.00
NEXTCURE INC (NXTC) United States $0.315B 0.00
Cyclerion Therapeutics (CYCN) United States $0.308B 0.00
PHASEBIO PHARMA (PHAS) United States $0.304B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.300B 0.00
Evelo Biosciences (EVLO) United States $0.278B 0.00
Geron (GERN) United States $0.272B 0.00
XBiotech (XBIT) United States $0.271B 0.00
Protagonist Therapeutics (PTGX) United States $0.270B 0.00
Sutro Biopharma (STRO) United States $0.268B 0.00
LogicBio Therapeutics (LOGC) United States $0.267B 0.00
Cellular Biomedicine (CBMG) United States $0.263B 0.00
Athersys (ATHX) United States $0.259B 0.00
Inovio Pharmaceuticals (INO) United States $0.247B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.246B 0.00
Urovant Sciences (UROV) United States $0.242B 0.00
Cel-Sci (CVM) United States $0.242B 0.00
Chiasma (CHMA) United States $0.242B 0.00
Dynavax Technologies (DVAX) United States $0.237B 0.00
Palatin Technologies (PTN) United States $0.237B 0.00
Spero Therapeutics (SPRO) United States $0.237B 0.00
Constellation Pharmaceuticals (CNST) United States $0.233B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.229B 0.00
Abeona Therapeutics (ABEO) United States $0.227B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.226B 0.00
Synlogic (SYBX) United States $0.226B 0.00
Five Prime Therapeutics (FPRX) United States $0.220B 0.00
Kamada (KMDA) Israel $0.218B 8.45
Avid Bioservices (CDMO) United States $0.217B 0.00
Kadmon Holdings (KDMN) United States $0.214B 0.00
Neothetics (EVFM) United States $0.213B 0.00
AXCELLA HEALTH (AXLA) United States $0.212B 0.00
MannKind (MNKD) United States $0.210B 0.00
ChromaDex (CDXC) United States $0.210B 0.00
ADMA Biologics Inc (ADMA) United States $0.209B 0.00
Cerecor (CERC) United States $0.209B 0.00
Celcuity (CELC) United States $0.207B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.206B 0.00
Mersana Therapeutics (MRSN) United States $0.204B 0.00
Compugen (CGEN) Israel $0.201B 0.00
Pfenex (PFNX) United States $0.195B 0.00
Kala Pharmaceuticals (KALA) United States $0.194B 0.00
IDEAYA BIOSCI (IDYA) United States $0.192B 0.00
Enochian BioSciences (ENOB) United States $0.190B 0.00
BICYCLE THERAPT (BCYC) United Kingdom $0.188B 0.00
CorMedix Inc (CRMD) United States $0.184B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.182B 0.00
Arsanis (XFOR) United States $0.182B 0.00
OSMOTICA PHARM (OSMT) United States $0.176B 0.00
Solid Biosciences (SLDB) United States $0.171B 0.00
Strongbridge Biopharma (SBBP) United States $0.171B 9.84
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.168B 0.00
Affimed (AFMD) Germany $0.167B 0.00
Anavex Life Sciences (AVXL) United States $0.166B 0.00
Cue Biopharma (CUE) United States $0.165B 0.00
BioXcel Therapeutics (BTAI) United States $0.164B 0.00
BioTime (BTX) United States $0.159B 10.60
OvaScience (MLND) United States $0.157B 0.00
Liquidia Technologies (LQDA) United States $0.156B 0.00
Dyadic (DYAI) United States $0.156B 0.00
TOCAGEN INC (TOCA) United States $0.151B 0.00
Kezar Life Sciences (KZR) United States $0.146B 0.00
Axovant Sciences (AXGT) United States $0.146B 0.00
Menlo Therapeutics (MNLO) United States $0.144B 0.00
APPLIED THERAPT (APLT) United States $0.143B 0.00
Aduro Biotech (ADRO) United States $0.143B 0.00
TREVI THERAPTCS (TRVI) United States $0.141B 0.00
Intec Pharma (NTEC) Israel $0.139B 0.00
XOMA (XOMA) United States $0.139B 0.00
HOOKIPA PHARMA (HOOK) United States $0.138B 0.00
Mustang Bio (MBIO) United States $0.138B 0.00
Arbutus Biopharma (ABUS) Canada $0.138B 0.00
Novavax (NVAX) United States $0.132B 0.00
Alcobra (ARCT) United States $0.128B 0.00
Checkpoint Therapeutics (CKPT) United States $0.128B 0.00
Eton Pharmaceuticals (ETON) United States $0.128B 0.00
Verastem (VSTM) United States $0.127B 0.00
Aptose Biosciences (APTO) Canada $0.125B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.122B 0.00
Gamida Cell (GMDA) Israel $0.121B 0.00
VolitionRX (VNRX) Singapore $0.119B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.119B 0.00
SESEN BIO, INC (SESN) United States $0.116B 0.00
Celyad SA (CYAD) Belgium $0.116B 0.00
Seres Therapeutics (MCRB) United States $0.115B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.114B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.114B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.111B 0.00
VBI Vaccines (VBIV) United States $0.109B 0.00
Aptinyx (APTX) United States $0.109B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.109B 0.00
NantKwest (NK) United States $0.109B 0.00
Fortress Biotech (FBIO) United States $0.108B 0.00
Equillium (EQ) United States $0.103B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.100B 0.00
Allena Pharmaceuticals (ALNA) United States $0.093B 0.00
INmune Bio (INMB) United States $0.091B 0.00
Catalyst Biosciences (CBIO) United States $0.091B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.090B 0.00
Trevena (TRVN) United States $0.089B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.087B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.086B 0.00
Selecta Biosciences (SELB) United States $0.086B 0.00
Pluristem Therapeutics (PSTI) Israel $0.085B 0.00
InflaRx (IFRX) Germany $0.079B 0.00
Cohbar (CWBR) United States $0.079B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.077B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.077B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.074B 0.00
Signal Genetics (MGEN) United States $0.072B 0.00
OVID THERAPEUTC (OVID) United States $0.070B 0.00
Unum Therapeutics (UMRX) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.068B 37.50
VTv Therapeutics (VTVT) United States $0.068B 0.00
ARAVIVE, INC (ARAV) United States $0.068B 0.00
Protalix BioTherapeutics (PLX) Israel $0.068B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.067B 0.00
Orgenesis (ORGS) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.066B 0.00
Cocrystal Pharma (COCP) United States $0.065B 69.00
Alimera Sciences (ALIM) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.062B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
DiaMedica Therapeutics (DMAC) United States $0.058B 0.00
Vaccinex (VCNX) United States $0.058B 0.00
Curis (CRIS) United States $0.056B 0.00
Zosano Pharma (ZSAN) United States $0.055B 0.00
ScPharmaceuticals (SCPH) United States $0.055B 0.00
Hoth Therapeutics (HOTH) United States $0.054B 0.00
Moleculin Biotech (MBRX) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.053B 0.00
Ophthotech (ISEE) United States $0.052B 0.00
Proteostasis Therapeutics (PTI) United States $0.052B 0.00
Eyenovia (EYEN) United States $0.052B 0.00
Organovo Holdings (ONVO) United States $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.049B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
Bellerophon Therapeutics (BLPH) United States $0.045B 0.00
AEterna Zentaris (AEZS) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Cidara Therapeutics (CDTX) United States $0.043B 0.00
Aptevo Therapeutics (APVO) United States $0.040B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Clearside Biomedical (CLSD) United States $0.039B 0.00
Leap Therapeutics (LPTX) United States $0.038B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
Entera Bio (ENTX) Israel $0.037B 0.00
VIVUS (VVUS) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
AZURRX BIOPHARM (AZRX) United States $0.036B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.033B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.032B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.032B 0.00
Aytu Bioscience (AYTU) United States $0.030B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Edge Therapeutics (PDSB) United States $0.030B 0.00
Bison Capital Acquisition (XYN) China $0.029B 0.00
Bionano Genomics (BNGO) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Oragenics (OGEN) United States $0.025B 0.00
Sophiris Bio (SPHS) United States $0.023B 0.00
TRACON Pharmaceuticals (TCON) United States $0.023B 0.00
Rexahn Pharmaceuticals (REXN) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Vical (VICL) United States $0.019B 0.00
Adial Pharmaceuticals (ADIL) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
GENPREX INC (GNPX) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Histogenics (HSGX) United States $0.019B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
OncoSec Medical (ONCS) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
IBio (IBIO) United States $0.014B 0.00
Vital Therapies (IMUX) United States $0.014B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Advaxis (ADXS) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Aileron Therapeutics (ALRN) United States $0.011B 0.00
IMMURON LTD (IMRN) Australia $0.011B 0.00
Motif Bio Plc (MTFB) United States $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Therapix Biosciences (TRPX) Israel $0.009B 0.00
AmpliPhi Biosciences (ARMP) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.008B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Stellar Biotechnologies (EDSA) United States $0.006B 0.00
Neuralstem (CUR) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Galena Biopharma (SLS) United States $0.003B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.000B 0.00